We hypothesize that the antagonistic effect of FS on ACT A could be improved by up-regulating FS expression or exogenous FS and by reversing the imbalance between ACT A and FS, and thus the left ventricular remodeling, heart failure, and myocardial fibrosis could be attenuated. This evidence concerns the gene SERPINA3 and heart failure.